Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Agios Pharmaceuticals, Inc. (AGIO)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Agios Pharmaceuticals, Inc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1439222.
Total stock buying since 2015: $225,626,257.
Total stock sales since 2015: $157,286,004.
Total stock option exercises since 2015: $24,780,238.
Table 3. Detailed insider trading at Agios Pharmaceuticals, Inc. (AGIO) , Part 4
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2017-06-07 | Schenkein David P (Chief Executive Officer) | Sale | 1,900 | 50.02 | 95,038 |
| 2017-06-07 | Schenkein David P (Chief Executive Officer) | Option Ex | 1,900 | .30 | 575 |
| 2017-06-06 | Schenkein David P (Chief Executive Officer) | Sale | 1,100 | 50.02 | 55,022 |
| 2017-06-06 | Schenkein David P (Chief Executive Officer) | Option Ex | 1,100 | .30 | 333 |
| 2017-05-25 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,018 | 46.92 | 47,764 |
| 2017-05-24 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,018 | 47.27 | 48,120 |
| 2017-05-01 | Schenkein David P (Chief Executive Officer) | Sale | 3,000 | 50.06 | 150,180 |
| 2017-05-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 3,000 | .30 | 909 |
| 2017-04-24 | Celgene Corp /de/ (10% Owner) | Buy | 1,873,725 | 49.50 | 92,749,386 |
| 2017-04-18 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,018 | 50.92 | 51,836 |
| 2017-04-17 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,072 | 55.20 | 224,774 |
| 2017-04-03 | Biller Scott (Chief Scientific Officer) | Sale | 2,146 | 58.03 | 124,532 |
| 2017-04-03 | Biller Scott (Chief Scientific Officer) | Option Ex | 2,146 | 9.05 | 19,421 |
| 2017-04-03 | Schenkein David P (Chief Executive Officer) | Sale | 3,000 | 58.62 | 175,860 |
| 2017-04-03 | Schenkein David P (Chief Executive Officer) | Option Ex | 3,000 | .30 | 909 |
| 2017-03-23 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,018 | 53.91 | 54,880 |
| 2017-03-22 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,018 | 52.31 | 53,251 |
| 2017-03-20 | Biller Scott (Chief Scientific Officer) | Sale | 6,438 | 55.00 | 354,090 |
| 2017-03-20 | Biller Scott (Chief Scientific Officer) | Option Ex | 6,438 | 4.76 | 30,638 |
| 2017-03-01 | Schenkein David P (Chief Executive Officer) | Sale | 3,000 | 50.47 | 151,410 |
| 2017-03-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 3,000 | .30 | 909 |
| 2017-02-28 | Nelsen Robert (Director) | Sale | 47,859 | 49.82 | 2,384,431 |
| 2017-02-27 | Nelsen Robert (Director) | Sale | 195,223 | 49.26 | 9,616,294 |
| 2017-02-23 | Nelsen Robert (Director) | Sale | 50,996 | 48.24 | 2,459,894 |
| 2017-02-22 | Nelsen Robert (Director) | Sale | 47,938 | 50.12 | 2,402,892 |
| 2017-02-21 | Nelsen Robert (Director) | Sale | 36,430 | 52.37 | 1,907,656 |
| 2017-02-16 | Schenkein David P (Chief Executive Officer) | Sale | 6,000 | 50.01 | 300,060 |
| 2017-02-16 | Schenkein David P (Chief Executive Officer) | Option Ex | 6,000 | .30 | 1,818 |
| 2016-11-14 | Biller Scott (Chief Scientific Officer) | Sale | 32,500 | 65.00 | 2,112,500 |
| 2016-11-14 | Biller Scott (Chief Scientific Officer) | Option Ex | 27,500 | 13.72 | 377,272 |
| 2016-11-10 | Biller Scott (Chief Scientific Officer) | Sale | 2,128 | 60.00 | 127,680 |
| 2016-11-09 | Biller Scott (Chief Scientific Officer) | Sale | 2,872 | 60.00 | 172,320 |
| 2016-10-27 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 48.97 | 61,310 |
| 2016-10-26 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 48.91 | 61,235 |
| 2016-10-05 | Biller Scott (Chief Scientific Officer) | Sale | 5,000 | 55.00 | 275,000 |
| 2016-09-28 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 54.00 | 67,608 |
| 2016-09-27 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 54.15 | 67,795 |
| 2016-09-20 | Biller Scott (Chief Scientific Officer) | Sale | 5,000 | 50.00 | 250,000 |
| 2016-08-30 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 36.81 | 46,086 |
| 2016-08-29 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 37.81 | 47,338 |
| 2016-07-26 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 43.74 | 54,762 |
| 2016-07-25 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 41.85 | 52,396 |
| 2016-06-28 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 43.38 | 54,311 |
| 2016-06-27 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 40.37 | 50,543 |
| 2016-06-10 | Biller Scott (Chief Scientific Officer) | Option Ex | 15,200 | .47 | 7,113 |
| 2016-06-08 | Biller Scott (Chief Scientific Officer) | Sale | 27,500 | 65.00 | 1,787,500 |
| 2016-06-08 | Biller Scott (Chief Scientific Officer) | Option Ex | 27,500 | 16.05 | 441,484 |
| 2016-05-26 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 52.88 | 66,205 |
| 2016-05-25 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 50.50 | 63,226 |
| 2016-04-26 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 51.88 | 64,953 |
| 2016-04-25 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 55.00 | 68,860 |
| 2016-03-30 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 38.09 | 47,688 |
| 2016-03-29 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 36.28 | 45,422 |
| 2016-02-03 | Biller Scott (Chief Scientific Officer) | Option Ex | 10,000 | .47 | 4,680 |
| 2016-01-29 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 41.52 | 51,983 |
| 2016-01-28 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,252 | 44.33 | 55,501 |
| 2016-01-07 | Biller Scott (Chief Scientific Officer) | Option Ex | 15,000 | .47 | 7,020 |
| 2016-01-07 | Schenkein David P (Chief Executive Officer) | Option Ex | 20,000 | .30 | 6,060 |
| 2016-01-05 | Schenkein David P (Chief Executive Officer) | Option Ex | 10,000 | .30 | 3,030 |
| 2016-01-04 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 58,999 | 16.99 | 1,002,393 |
| 2016-01-04 | Schenkein David P (Chief Executive Officer) | Option Ex | 10,000 | .30 | 3,030 |
| 2015-12-31 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 65.27 | 358,985 |
| 2015-12-31 | Biller Scott (Chief Scientific Officer) | Option Ex | 5,500 | 31.64 | 174,020 |
| 2015-12-29 | Cantley Lewis Clayton Jr. (Director) | Sale | 5,340 | 66.14 | 353,160 |
| 2015-12-28 | Cantley Lewis Clayton Jr. (Director) | Sale | 5,324 | 63.73 | 339,271 |
| 2015-12-15 | Higgons John Duncan (Chief Operating Officer) | Sale | 20,000 | 50.09 | 1,001,800 |
| 2015-11-30 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 65.99 | 362,945 |
| 2015-11-30 | Biller Scott (Chief Scientific Officer) | Option Ex | 5,500 | 31.64 | 174,020 |
| 2015-11-17 | Cantley Lewis Clayton Jr. (Director) | Sale | 6,982 | 59.98 | 418,815 |
| 2015-11-16 | Higgons John Duncan (Chief Operating Officer) | Sale | 20,000 | 61.51 | 1,230,200 |
| 2015-11-16 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 20,000 | 1.09 | 21,860 |
| 2015-11-16 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,426 | 59.38 | 144,055 |
| 2015-11-02 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 77.12 | 424,160 |
| 2015-11-02 | Biller Scott (Chief Scientific Officer) | Option Ex | 5,500 | 31.64 | 174,020 |
| 2015-10-27 | Schenkein David P (Chief Executive Officer) | Sale | 4,000 | 80.26 | 321,040 |
| 2015-10-27 | Schenkein David P (Chief Executive Officer) | Option Ex | 4,000 | 31.64 | 126,560 |
| 2015-10-23 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 61.10 | 296,481 |
| 2015-10-22 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 61.22 | 297,015 |
| 2015-10-15 | Higgons John Duncan (Chief Operating Officer) | Sale | 20,000 | 71.04 | 1,420,800 |
| 2015-10-15 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 20,000 | .36 | 7,160 |
| 2015-09-30 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 70.44 | 387,420 |
| 2015-09-30 | Biller Scott (Chief Scientific Officer) | Option Ex | 5,500 | 31.64 | 174,020 |
| 2015-09-30 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 10,000 | .30 | 3,030 |
| 2015-09-25 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 82.08 | 398,252 |
| 2015-09-24 | Goddard Glenn (Senior Vice President, Finance) | Sale | 6,000 | 85.97 | 515,820 |
| 2015-09-24 | Goddard Glenn (Senior Vice President, Finance) | Option Ex | 10,856 | 11.55 | 125,386 |
| 2015-09-24 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 84.42 | 409,630 |
| 2015-09-15 | Higgons John Duncan (Chief Operating Officer) | Sale | 20,000 | 91.11 | 1,822,200 |
| 2015-09-15 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 20,000 | .30 | 6,060 |
| 2015-08-20 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 10,000 | .30 | 3,030 |
| 2015-08-18 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 95.69 | 464,287 |
| 2015-08-17 | Higgons John Duncan (Chief Operating Officer) | Sale | 20,000 | 92.24 | 1,844,800 |
| 2015-08-17 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 20,000 | .30 | 6,060 |
| 2015-08-17 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 94.19 | 457,034 |
| 2015-08-10 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 100.00 | 550,000 |
| 2015-08-10 | Biller Scott (Chief Scientific Officer) | Option Ex | 5,500 | 31.64 | 174,020 |
| 2015-08-06 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 10,000 | .30 | 3,030 |
| 2015-08-03 | Schenkein David P (Chief Executive Officer) | Sale | 8,000 | 110.60 | 884,800 |
| 2015-08-03 | Schenkein David P (Chief Executive Officer) | Option Ex | 8,000 | 15.97 | 127,768 |
| 2015-07-23 | Goddard Glenn (Senior Vice President, Finance) | Sale | 7,000 | 120.45 | 843,150 |
| 2015-07-23 | Goddard Glenn (Senior Vice President, Finance) | Option Ex | 7,000 | 27.37 | 191,590 |
| 2015-07-20 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 113.87 | 626,285 |
| 2015-07-20 | Biller Scott (Chief Scientific Officer) | Option Ex | 5,500 | 31.64 | 174,020 |
| 2015-07-17 | Goddard Glenn (Senior Vice President, Finance) | Sale | 13,000 | 113.71 | 1,478,230 |
| 2015-07-17 | Goddard Glenn (Senior Vice President, Finance) | Option Ex | 13,000 | 8.79 | 114,322 |
| 2015-07-16 | Higgons John Duncan (Chief Operating Officer) | Sale | 20,000 | 114.02 | 2,280,400 |
| 2015-07-16 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 20,000 | .30 | 6,060 |
| 2015-07-16 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 114.19 | 554,025 |
| 2015-07-15 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 114.36 | 554,898 |
| 2015-06-26 | Biller Scott (Chief Scientific Officer) | Option Ex | 7,500 | .47 | 3,510 |
| 2015-06-25 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 105.66 | 512,662 |
| 2015-06-24 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 104.59 | 507,494 |
| 2015-06-16 | Biller Scott (Chief Scientific Officer) | Option Ex | 300 | .47 | 140 |
| 2015-06-15 | Higgons John Duncan (Chief Operating Officer) | Sale | 7,000 | 105.23 | 736,610 |
| 2015-06-12 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 10,000 | .30 | 3,030 |
| 2015-06-11 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 10,000 | .30 | 3,030 |
| 2015-06-10 | Higgons John Duncan (Chief Operating Officer) | Option Ex | 10,000 | .30 | 3,030 |
| 2015-06-08 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 121.85 | 670,175 |
| 2015-06-01 | Bowden Christopher (Chief Medical Officer) | Sale | 5,000 | 120.67 | 603,350 |
| 2015-06-01 | Bowden Christopher (Chief Medical Officer) | Option Ex | 5,000 | 35.16 | 175,799 |
| 2015-06-01 | Schenkein David P (Chief Executive Officer) | Sale | 13,000 | 120.67 | 1,568,710 |
| 2015-05-27 | Goddard Glenn (Senior Vice President, Finance) | Sale | 2,171 | 120.05 | 260,628 |
| 2015-05-27 | Goddard Glenn (Senior Vice President, Finance) | Option Ex | 2,171 | 23.10 | 50,150 |
| 2015-05-27 | Schenkein David P (Chief Executive Officer) | Sale | 8,929 | 120.05 | 1,071,926 |
| 2015-05-20 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 116.60 | 565,743 |
| 2015-05-19 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 116.67 | 566,107 |
| 2015-05-15 | Higgons John Duncan (Chief Operating Officer) | Sale | 7,417 | 112.89 | 837,305 |
| 2015-05-12 | Schenkein David P (Chief Executive Officer) | Sale | 2,093 | 110.03 | 230,292 |
| 2015-05-11 | Schenkein David P (Chief Executive Officer) | Sale | 3,107 | 110.01 | 341,801 |
| 2015-05-08 | Schenkein David P (Chief Executive Officer) | Sale | 3,900 | 101.32 | 395,148 |
| 2015-05-07 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 96.32 | 529,760 |
| 2015-05-07 | Schenkein David P (Chief Executive Officer) | Option Ex | 10,000 | .30 | 3,030 |
| 2015-05-01 | Schenkein David P (Chief Executive Officer) | Sale | 3,900 | 93.63 | 365,157 |
| 2015-04-24 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 106.47 | 516,592 |
| 2015-04-23 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 103.83 | 503,758 |
| 2015-04-15 | Higgons John Duncan (Chief Operating Officer) | Sale | 6,583 | 99.54 | 655,271 |
| 2015-04-13 | Schenkein David P (Chief Executive Officer) | Sale | 3,900 | 100.03 | 390,117 |
| 2015-04-08 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 97.64 | 537,020 |
| 2015-04-01 | Schenkein David P (Chief Executive Officer) | Sale | 3,900 | 92.54 | 360,906 |
| 2015-03-27 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 96.34 | 467,441 |
| 2015-03-26 | Cantley Lewis Clayton Jr. (Director) | Sale | 4,852 | 90.83 | 440,682 |
| 2015-03-16 | Goddard Glenn (Senior Vice President, Finance) | Sale | 10,000 | 106.24 | 1,062,400 |
| 2015-03-16 | Goddard Glenn (Senior Vice President, Finance) | Option Ex | 10,000 | 18.48 | 184,770 |
| 2015-03-16 | Biller Scott (Chief Scientific Officer) | Sale | 5,500 | 106.81 | 587,455 |
| 2015-03-16 | Biller Scott (Chief Scientific Officer) | Option Ex | 5,500 | .47 | 2,574 |
| 2015-03-16 | Higgons John Duncan (Chief Operating Officer) | Sale | 7,000 | 106.24 | 743,680 |
| 2015-03-05 | Schenkein David P (Chief Executive Officer) | Sale | 2,600 | 110.16 | 286,416 |
| 2015-03-02 | Schenkein David P (Chief Executive Officer) | Sale | 7,800 | 107.05 | 834,990 |
| 2015-02-27 | Schenkein David P (Chief Executive Officer) | Option Ex | 25,000 | .30 | 7,575 |
| 2015-02-13 | Goddard Glenn (Senior Vice President, Finance) | Sale | 1,316 | 120.31 | 158,327 |
| 2015-02-13 | Goddard Glenn (Senior Vice President, Finance) | Option Ex | 1,316 | 23.10 | 30,399 |
| 2015-02-13 | Schenkein David P (Chief Executive Officer) | Sale | 684 | 120.31 | 82,292 |
| 2015-02-11 | Goddard Glenn (Senior Vice President, Finance) | Sale | 1,513 | 120.14 | 181,771 |
| 2015-02-11 | Goddard Glenn (Senior Vice President, Finance) | Option Ex | 1,513 | 23.10 | 34,950 |
| 2015-02-11 | Schenkein David P (Chief Executive Officer) | Sale | 787 | 120.14 | 94,550 |
| 2015-02-09 | Goddard Glenn (Senior Vice President, Finance) | Sale | 15,000 | 105.81 | 1,587,150 |
| 2015-02-09 | Goddard Glenn (Senior Vice President, Finance) | Option Ex | 15,000 | 11.89 | 178,410 |
| 2015-02-02 | Schenkein David P (Chief Executive Officer) | Sale | 10,400 | 114.31 | 1,188,824 |
| 2015-01-02 | Biller Scott (Chief Scientific Officer) | Sale | 4,500 | 110.08 | 495,360 |
| 2015-01-02 | Biller Scott (Chief Scientific Officer) | Option Ex | 4,500 | .47 | 2,106 |
| 2015-01-02 | Higgons John Duncan (Chief Operating Officer) | Sale | 24,000 | 110.08 | 2,641,920 |
| 2015-01-02 | Schenkein David P (Chief Executive Officer) | Sale | 13,000 | 110.08 | 1,431,040 |
Insider trading activities including stock purchases, stock sales, and option exercises
of AGIO listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Agios Pharmaceuticals, Inc. (symbol AGIO,
CIK number 1439222) see
the Securities and Exchange Commission (SEC) website.